Future at Risk: What Happens when Funding Stops
Live from Stage 4 | Episode # 3 | 10/07/2025 | Interview with Dr. Gloria Echeverria, PhD
Guest
Dr. Gloria Vittone Echeverria, PhD
An assistant professor at Baylor College of Medicine and a leading cancer researcher specializing in triple-negative breast cancer (TNBC). She leads the Echeverria Lab, which focuses on understanding how these cancers resist chemotherapy and metastasize to other parts of the body.
Listen to full episode :
Quick Summary
Takeaways
Dr. Gloria Echevarria’s lab at Baylor College of Medicine focuses on understanding and developing new treatments for triple negative breast cancer, a particularly aggressive and hard-to-treat subtype.
Federal funding cuts and uncertainty are significantly impacting research labs, leading to fewer opportunities for young scientists and forcing labs to scale back or pause important projects.
Diversifying funding sources beyond federal grants is now essential for research labs to survive and continue their work.
Despite the challenges, ongoing scientific collaboration and innovation are leading to promising breakthroughs, and Dr. Echevarria remains hopeful about the future of cancer research.
Resources Mentioned
✅ Important article — Perspective of a breast cancer researcher facing drastic cuts to academic research funding and disruptions to critical grant review processes, highlighting the devastating impact on lifesaving biomedical research. Read: this link (Must-read)